N Pillay, A Tighe, L Nelson, S Littler, C Coulson-Gilmer… - Cancer Cell, 2019 - cell.com
Inhibitors of poly (ADP-ribose) polymerase (PARP) have demonstrated efficacy in women
with BRCA-mutant ovarian cancer. However, only 15%–20% of ovarian cancers harbor …